HIGHLIGHTS
- who: Xiaoyu Zhang from the Yale University, United States have published the research work: Advances in Stigmasterol on its anti-tumor effect and mechanism of action, in the Journal: (JOURNAL)
- how: The results indicated that Nrf2 was significant in chemoresistance in endometrial cancer and it had potential to inhibit Cisplatin resistance as a novel potential inhibitor of Nrf2. breast cancer continues to increase annually severely affecting the quality of life of patients and inflicting a heavy burden on the patient family and society . The authors declare that the research was conducted in the absence of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.